Aurinia Pharmaceuticals Inc.
AUPH
$15.19
$0.281.88%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 46.66% | -7.84% | 1,533.59% | -90.04% | 1,887.53% |
| Total Depreciation and Amortization | 0.02% | 0.16% | -0.12% | -0.63% | 1.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -66.49% | 729.51% | -243.56% | -85.39% | 78.84% |
| Change in Net Operating Assets | -30.75% | 122.93% | -211.09% | 297.05% | -322.08% |
| Cash from Operations | 0.47% | 3,303.15% | -95.68% | 76.84% | 7.49% |
| Capital Expenditure | 33.67% | -476.47% | 93.95% | -300.71% | 209.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.04% | -142.43% | -21.40% | 468.78% | 72.17% |
| Cash from Investing | -3.76% | -142.77% | -20.88% | 471.01% | 72.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -0.52% | -23.78% | 8.55% | -2.43% | 8.22% |
| Issuance of Common Stock | 17.03% | -81.66% | 17.24% | 1,865.76% | -69.31% |
| Repurchase of Common Stock | 78.82% | 23.61% | -99.92% | -16,629.34% | 97.38% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 76.37% | 10.02% | -114.08% | -746.66% | 67.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 250.36% | 21.05% | -136.74% | 1,139.38% | 112.03% |